Literature DB >> 16504888

Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.

Dean Y Kim1, David S Kwon, Riad Salem, Chan K Ma, Marwan S Abouljoud.   

Abstract

We report a case of a patient with end-stage liver disease secondary to hepatitis C, complicated by a large hepatocellular carcinoma. Because of the size of the tumor exceeded the Milan criteria, he was not a candidate for liver transplantation. However, after two treatments with yttrium-90 glass microsphere infusions, the tumor became smaller and the patient's alpha-fetoprotein level dropped to normal range. He was listed for transplantation and subsequently received a deceased donor liver transplant. Two years after his transplantation, he remains tumor free and has normal alpha-fetoprotein levels. This is the first reported case in the literature of using yttrium-90 microspheres as a bridge to liver transplantation in a patient with a large hepatocellular carcinoma. This therapy should be considered in patients with cirrhosis and large hepatocellular carcinomas exceeding current size criterion, who would otherwise be good candidates for transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504888     DOI: 10.1016/j.gassur.2005.06.019

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

Review 1.  New nonsurgical therapies in the treatment of hepatocellular carcinoma.

Authors:  C S Georgiades; D E Ramsey; S Solomon; J F Geschwind
Journal:  Tech Vasc Interv Radiol       Date:  2001-09

2.  Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

Authors:  James E Goin; Riad Salem; Brian I Carr; Janet E Dancey; Michael C Soulen; Jean-Francois H Geschwind; Kathleen Goin; Mark Van Buskirk; Kenneth Thurston
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

3.  Hepatocellular carcinoma.

Authors:  A M Di Bisceglie; R L Carithers; G J Gores
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

4.  Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.

Authors:  Christoph Herold; Thomas Reck; Peter Fischler; Rudolf Ott; Martin Radespiel-Troeger; Marion Ganslmayer; Werner Hohenberger; Eckhart G Hahn; Detlef Schuppan
Journal:  Liver       Date:  2002-02

5.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

6.  Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

Authors:  G Otto; U Heuschen; W J Hofmann; G Krumm; U Hinz; C Herfarth
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

Review 7.  Surgery and ablative therapy for hepatocellular carcinoma.

Authors:  Charles Cha; Ronald P DeMatteo; Leslie H Blumgart
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

8.  Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.

Authors:  Brian I Carr
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

Review 9.  Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.

Authors:  Riad Salem; Kenneth G Thurston; Brian I Carr; James E Goin; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

10.  Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies.

Authors:  J H Tian; B X Xu; J M Zhang; B W Dong; P Liang; X D Wang
Journal:  J Nucl Med       Date:  1996-06       Impact factor: 10.057

View more
  9 in total

1.  Radioembolization of yttrium-90 microspheres for hepatic malignancy.

Authors:  Ravi Murthy; Paresh Kamat; Rodolfo Nuñez; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

2.  Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension.

Authors:  Nerea Fernández-Ros; Nuno Silva; Jose Ignacio Bilbao; Mercedes Iñarrairaegui; Alberto Benito; Delia D'Avola; Macarena Rodriguez; Fernando Rotellar; Fernando Pardo; Bruno Sangro
Journal:  HPB (Oxford)       Date:  2013-03-27       Impact factor: 3.647

Review 3.  [Therapy of hepatocellular carcinoma before liver transplantation].

Authors:  M Guba; M Angele; M Rentsch; K W Jauch; R Zachoval; F Kolligs; A Gerbes; C J Bruns
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

4.  Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.

Authors:  Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Andrea Laurenzi; Marco Colasanti; Roberto Luca Meniconi; Raffaella Lionetti; Roberto Santoro; Pasquale Lepiane; Rosa Sciuto; Giuseppe Pizzi; Roberto Cianni; Rita Golfieri; Gianpiero D'Offizi; Adriano M Pellicelli; Mario Antonini; Giovanni Vennarecci
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 5.  [Tumor and transplantation].

Authors:  M Guba; J Andrassy; M Angele; C Bruns
Journal:  Chirurg       Date:  2013-08       Impact factor: 0.955

Review 6.  Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.

Authors:  Giovanni Battista Levi Sandri; Giuseppe Maria Ettorre; Valerio Giannelli; Marco Colasanti; Rosa Sciuto; Giuseppe Pizzi; Roberto Cianni; Gianpiero D'Offizi; Mario Antonini; Giovanni Vennarecci; Pierleone Lucatelli
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-27

7.  Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.

Authors:  Sean Garrean; Amanda Muhs; James T Bui; Michael J Blend; Charles Owens; William S Helton; N Joseph Espat
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

8.  Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.

Authors:  R Murthy; A Habbu; R Salem
Journal:  Biomed Imaging Interv J       Date:  2006-07-01

9.  Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment.

Authors:  Sonia Radunz; Jürgen Treckmann; Hideo A Baba; Jan Best; Stefan Müller; Jens M Theysohn; Andreas Paul; Tamás Benkö
Journal:  Ann Transplant       Date:  2017-04-14       Impact factor: 1.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.